Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) SHH
47.71
+1.03(+2.21%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Chengdu Easton Biopharmaceuticals Co., Ltd.
Address
No.8, Xiyuan Avenue
Chengdu, 611731
China
Phone
86 28 6758 5121
Website
Sector
Healthcare
Industry
Biotechnology
Employees
1400
First IPO Date
September 02, 2020
Key Executives
| Name | Title | Pay | Year Born |
| Daming Zhang | Deputy GM & Director | 0 | 1973 |
| Xiao Qin Bo | Chief Financial Officer, Accounting Supervisor & Director | 0 | 1982 |
| Avinash Ramkisan Mane | Chief Scientist of Formulation Research Department & Core Technician | 0 | 1978 |
| Haibin Guo | Manager of Formulation Research Department & Core Technician | 0 | 1981 |
| Shuyun Li | Board Secretary | 0 | 1985 |
| Mingxu Yuan | GM & Director | 0 | 1972 |
| Xingyao Song | Deputy General Manager | 0 | 1977 |
| Zheng Pin Guan | Deputy GM & Core Technician | 0 | 1974 |
Description
Chengdu Easton Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms in anesthetic/analgesics, cardiovascular, oncology, pediatrics, and other therapeutic fields. It also offers active pharmaceutical ingredients in oncology, cardiovascular, anesthetic/analgesics, anti-inflammatory, gastrointestinal, antiemetic, neurology/psychiatry , and urinary system therapeutic categories. The company was founded in 2009 and is based in Chengdu, China.
